Yukinori Take

Person

Aichi, JP

People

Patents Grantslast 30 patents

Information Patent Grant
Selective EP4 receptor antagonistic substance for treatment of cancer
- Patent number 11,840,530
- Issue date Dec 12, 2023
- AskAt Inc.
- Yukinori Take
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
EP4 inhibitors and use thereof
- Patent number 10,973,834
- Issue date Apr 13, 2021
- Arrys Therapeutics, Inc.
- Mark Manfredi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Selective EP4 receptor antagonistic substance for treatment of cancer
- Patent number 10,947,235
- Issue date Mar 16, 2021
- AskAt Inc.
- Yukinori Take
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective EP4 receptor antagonistic substance for treatment of cancer
- Patent number 10,611,761
- Issue date Apr 7, 2020
- AskAt Inc.
- Yukinori Take
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective EP4 receptor antagonistic substance for treatment of cancer
- Patent number 9,688,674
- Issue date Jun 27, 2017
- AskAt Inc.
- Yukinori Take
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
5-HT4 receptor agonists for the treatment of dementia
- Patent number 8,980,922
- Issue date Mar 17, 2015
- Raqualia Pharma Inc.
- Hiroyuki Ohshiro
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Selective EP4 receptor antagonistic substance for treatment of cancer
- Patent number 8,921,391
- Issue date Dec 30, 2014
- Raqualia Pharma Inc.
- Yukinori Take
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
EP4 INHIBITORS AND USE THEREOF
- Publication number 20240066040
- Publication date Feb 29, 2024
- Arrys Therapeutics, Inc.
- Mark Manfredi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE EP4 RECEPTOR ANTAGONISTIC SUBSTANCE FOR TREATMENT OF CANCER
- Publication number 20220073510
- Publication date Mar 10, 2022
- AskAt Inc.
- Yukinori TAKE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EP4 INHIBITORS AND USE THEREOF
- Publication number 20210290641
- Publication date Sep 23, 2021
- Arrys Therapeutics, Inc.
- Mark Manfredi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE EP4 RECEPTOR ANTAGONISTIC SUBSTANCE FOR TREATMENT OF CANCER
- Publication number 20200188367
- Publication date Jun 18, 2020
- AskAt Inc.
- Yukinori TAKE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EP4 INHIBITORS AND USE THEREOF
- Publication number 20190314390
- Publication date Oct 17, 2019
- Arrys Therapeutics, Inc.
- Mark Manfredi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE EP4 RECEPTOR ANTAGONISTIC SUBSTANCE FOR TREATMENT OF CANCER
- Publication number 20170253595
- Publication date Sep 7, 2017
- AskAt Inc.
- Yukinori TAKE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE EP4 RECEPTOR ANTAGONISTIC SUBSTANCE FOR TREATMENT OF CANCER
- Publication number 20150111920
- Publication date Apr 23, 2015
- RAQUALIA PHARMA INC.
- Yukinori Take
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
5-HT4 RECEPTOR AGONISTS FOR THE TREATMENT OF DEMENTIA
- Publication number 20120322826
- Publication date Dec 20, 2012
- RQUALIA PHAMRA INC.
- Hiroyuki Ohshiro
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE EP4 RECEPTOR AGONISTIC SUBSTANCE FOR TREATMENT OF CANCER
- Publication number 20120088723
- Publication date Apr 12, 2012
- RAQUALIA PHARMA INC.
- Yukinori Take
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Yukinori Take

Person

Patents Grantslast 30 patents

Selective EP4 receptor antagonistic substance for treatment of cancer

EP4 inhibitors and use thereof

Selective EP4 receptor antagonistic substance for treatment of cancer

Selective EP4 receptor antagonistic substance for treatment of cancer

Selective EP4 receptor antagonistic substance for treatment of cancer

5-HT4 receptor agonists for the treatment of dementia

Selective EP4 receptor antagonistic substance for treatment of cancer

Patents Applicationslast 30 patents

EP4 INHIBITORS AND USE THEREOF

SELECTIVE EP4 RECEPTOR ANTAGONISTIC SUBSTANCE FOR TREATMENT OF CANCER

EP4 INHIBITORS AND USE THEREOF

SELECTIVE EP4 RECEPTOR ANTAGONISTIC SUBSTANCE FOR TREATMENT OF CANCER

EP4 INHIBITORS AND USE THEREOF

SELECTIVE EP4 RECEPTOR ANTAGONISTIC SUBSTANCE FOR TREATMENT OF CANCER

SELECTIVE EP4 RECEPTOR ANTAGONISTIC SUBSTANCE FOR TREATMENT OF CANCER

5-HT4 RECEPTOR AGONISTS FOR THE TREATMENT OF DEMENTIA

SELECTIVE EP4 RECEPTOR AGONISTIC SUBSTANCE FOR TREATMENT OF CANCER